{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:33:39Z","timestamp":1771666419454,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T00:00:00Z","timestamp":1090540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study was designed to determine the prevalence of lupus anticoagulant (LA) antibody and several antibodies for antiphospholipid syndrome (APS) in patients with deep vein thrombosis (DVT)\/pulmonary embolism (PE) (<jats:italic>n<\/jats:italic> = 48), cerebral thrombosis (CT, <jats:italic>n<\/jats:italic> = 30), systemic lupus erythematosus (SLE, <jats:italic>n<\/jats:italic> = 22), and idiopathic thrombocytopenic purpura (ITP, <jats:italic>n<\/jats:italic> = 30). The presence of antibodies was examined by using the respective ELISA kits. LA was positive in 38.6% of patients with DVT\/PE, suggesting that LA is one of the most important risk factors in DVT\/PE. The highest prevalence of anti\u2010\u03b2<jats:sub>2<\/jats:sub> glycoprotein I (\u03b2<jats:sub>2<\/jats:sub>GPI) IgG was in CT and SLE, followed by DVT, and none in ITP and healthy volunteers (control, <jats:italic>n<\/jats:italic> = 40), suggesting that it is related to thrombosis, particularly arterial thrombosis. The highest prevalence of anti\u2010prothrombin (aPT) IgG antibody was in DVT, followed by CT and SLE, and none in ITP and the control, suggesting that it is related to thrombosis, especially venous thrombosis. The highest prevalence of antiphospholipid (aPL) IgG was in DVT, CT, and SLE, but 0% in ITP and control. On the other hand, aPL IgM, anti\u2010annexin V IgG, and anti\u2010annexin V IgM were positive in patients both with and without thrombosis, suggesting that they are not related to thrombosis. Our results indicated that among the anti\u2010phospholipid antibodies, LA is the most sensitive marker for APS while anti\u2010\u03b2<jats:sub>2<\/jats:sub>GPI IgG, aPT IgG, and aPL IgG are risk factors for thrombosis. In particular, aPT IgG is a significant marker for DVT\/PE. Am. J. Hematol. 76:338\u2013342, 2004. \u00a9 2004 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20124","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T17:03:13Z","timestamp":1090602193000},"page":"338-342","source":"Crossref","is-referenced-by-count":22,"title":["High prevalence of anti\u2010prothrombin antibody in patients with deep vein thrombosis"],"prefix":"10.1002","volume":"76","author":[{"given":"Ken","family":"Ishikura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kamikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyouko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Fukuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,23]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"32.1","volume-title":"Rheumatology","author":"Harris EN","year":"1994"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0307-742X(21)00606-8","article-title":"Antiphospholipid antibodies","volume":"11","author":"Harris EN","year":"1985","journal-title":"Clin Rheum Dis"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903253401201"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00060-6"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0038-1650551","article-title":"Deep vein thrombosis and lupus anticoagulant. A case\u2010control study","volume":"76","author":"Simioni P","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.2.140"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-0038-1650686","article-title":"Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus\u2014comparison between different assays for the detection of antiphospholipid antibodies","volume":"76","author":"Horbach DA","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.23.2.189"},{"key":"e_1_2_1_10_2","first-page":"S1","volume-title":"Stroke","author":"Antiphospholipid Antibodies in Stroke Study Group","year":"1993"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.1.23"},{"key":"e_1_2_1_12_2","first-page":"623","article-title":"The prevalence of anti\u2010cardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies","volume":"16","author":"Fields R","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-3666-8_2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.22.2195"},{"key":"e_1_2_1_16_2","first-page":"215","article-title":"Evaluation of the anti\u2010cardiolipin antibody test: report of an international workshop held April 4, 1986","volume":"68","author":"Harris EN","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_17_2","first-page":"121","article-title":"Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon","volume":"2","author":"Triplett DA","year":"1988","journal-title":"Hematol Pathol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91697-9"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1182\/blood.V61.4.684.684","article-title":"A mechanism for the hypoprothrombinemia of the acquired hypo\u2010prothrombinemia\u2010lupus anticoagulant syndrome","volume":"61","author":"Bajaj SP","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_20_2","first-page":"188","article-title":"Antithrombin and its inherited deficiency states","volume":"34","author":"Van Boven HH","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0037-1613820","article-title":"Protein C deficiency and venous thrombosis\u2014the search for the second genetic defect","volume":"83","author":"Bertina RM","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-5-677"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602960000600305"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919624"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.157.18.2101"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4601357.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03317.x"},{"key":"e_1_2_1_28_2","first-page":"237","article-title":"Prothrombin as a co\u2010factor of the circulating anticoagulant in systemic lupus erythematosus?","volume":"3","author":"Loeliger A","year":"1959","journal-title":"Thromb Diath Haemorrh"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0089"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1055\/s-0038-1657711","article-title":"High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle\u2010aged men. A nested case\u2010control study","volume":"78","author":"Palosuo T","year":"1997","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_31_2","first-page":"192","article-title":"Increased activated protein C\u2013protein C inhibitor complex levels in patients with pulmonary embolism","volume":"71","author":"Minamikawa N","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199510000-00002"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199404000-00003"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20124","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T02:16:10Z","timestamp":1700187370000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,23]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1002\/ajh.20124"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20124","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,23]]}}}